Etoricoxib dispersible tablets and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 万全万特制药江苏有限公司
- Publication Date
- 2015-05-06
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a pharmaceutical preparation in the category of oral rapid release, in particular to an etoricoxib dispersible tablet and a preparation method thereof. Background technique
[0002] Etoricoxib, chemical name is 5-chloro-6-methyl-3[4-(methylsulfonyl)phenyl]-2,3-bipyridine, molecular formula: C 18 h 15 CIN 2 o 2 S, molecular weight: 358.84, its structure is as follows:
[0003] .
[0004] Etoricoxib is a new type of highly selective COX-2 inhibitor, and its selective inhibitory effect on COX-2 is 100 times that of COX-1; in vitro studies have shown that etoricoxib has a strong selective effect on COX-2 than any other currently available COX-2 selective inhibitor. Etoricoxib has been approved for the treatment of osteoarthritis by more than 80 countries in Europe, Latin America, and Asia Pacific, and the recommended dose is 30 mg and 60 mg, once a day. A number of clinical studies have shown that the therapeutic effect of...